BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 238 hits with Last Name = 'vestergaard' and Initial = 'b'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Glutamate receptor 1


(Homo sapiens (Human))
BDBM50373889
PNG
(CHEMBL402444)
Show SMILES N[C@H](Cc1ns[nH]c1=O)C(O)=O |r|
Show InChI InChI=1S/C5H7N3O3S/c6-2(5(10)11)1-3-4(9)8-12-7-3/h2H,1,6H2,(H,8,9)(H,10,11)/t2-/m1/s1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
MMDB
PC cid
PC sid
UniChem

Similars

Article
PubMed
150n/an/an/an/an/an/an/an/a



University of Copenhagen

Curated by ChEMBL


Assay Description
Binding affinity at iGluR1o receptor expressed in sf9 cells by radioligand binding assay


J Med Chem 51: 1459-63 (2008)


Article DOI: 10.1021/jm701126w
BindingDB Entry DOI: 10.7270/Q2S75H6Z
More data for this
Ligand-Target Pair
Glutamate receptor 3


(Homo sapiens (Human))
BDBM50373890
PNG
(CHEMBL429594)
Show SMILES N[C@@H](Cc1ns[nH]c1=O)C(O)=O |r|
Show InChI InChI=1S/C5H7N3O3S/c6-2(5(10)11)1-3-4(9)8-12-7-3/h2H,1,6H2,(H,8,9)(H,10,11)/t2-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
MMDB
PC cid
PC sid
UniChem

Similars

MMDB
Article
PubMed
160n/an/an/an/an/an/an/an/a



University of Copenhagen

Curated by ChEMBL


Assay Description
Binding affinity at iGluR3o receptor expressed in sf9 cells by radioligand binding assay


J Med Chem 51: 1459-63 (2008)


Article DOI: 10.1021/jm701126w
BindingDB Entry DOI: 10.7270/Q2S75H6Z
More data for this
Ligand-Target Pair
Glutamate receptor 4


(Homo sapiens (Human))
BDBM50373890
PNG
(CHEMBL429594)
Show SMILES N[C@@H](Cc1ns[nH]c1=O)C(O)=O |r|
Show InChI InChI=1S/C5H7N3O3S/c6-2(5(10)11)1-3-4(9)8-12-7-3/h2H,1,6H2,(H,8,9)(H,10,11)/t2-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
MMDB
PC cid
PC sid
UniChem

Similars

Article
PubMed
182n/an/an/an/an/an/an/an/a



University of Copenhagen

Curated by ChEMBL


Assay Description
Binding affinity at iGluR4o receptor expressed in sf9 cells by radioligand binding assay


J Med Chem 51: 1459-63 (2008)


Article DOI: 10.1021/jm701126w
BindingDB Entry DOI: 10.7270/Q2S75H6Z
More data for this
Ligand-Target Pair
Glutamate receptor 1


(Homo sapiens (Human))
BDBM50373890
PNG
(CHEMBL429594)
Show SMILES N[C@@H](Cc1ns[nH]c1=O)C(O)=O |r|
Show InChI InChI=1S/C5H7N3O3S/c6-2(5(10)11)1-3-4(9)8-12-7-3/h2H,1,6H2,(H,8,9)(H,10,11)/t2-/m0/s1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
MMDB
PC cid
PC sid
UniChem

Similars

Article
PubMed
185n/an/an/an/an/an/an/an/a



University of Copenhagen

Curated by ChEMBL


Assay Description
Binding affinity at iGluR1o receptor expressed in sf9 cells by radioligand binding assay


J Med Chem 51: 1459-63 (2008)


Article DOI: 10.1021/jm701126w
BindingDB Entry DOI: 10.7270/Q2S75H6Z
More data for this
Ligand-Target Pair
Glutamate receptor 2


(Homo sapiens (Human))
BDBM50373889
PNG
(CHEMBL402444)
Show SMILES N[C@H](Cc1ns[nH]c1=O)C(O)=O |r|
Show InChI InChI=1S/C5H7N3O3S/c6-2(5(10)11)1-3-4(9)8-12-7-3/h2H,1,6H2,(H,8,9)(H,10,11)/t2-/m1/s1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
MMDB
PC cid
PC sid
UniChem

Similars

Article
PubMed
234n/an/an/an/an/an/an/an/a



University of Copenhagen

Curated by ChEMBL


Assay Description
Binding affinity at iGluR2o(R) receptor expressed in sf9 cells by radioligand binding assay


J Med Chem 51: 1459-63 (2008)


Article DOI: 10.1021/jm701126w
BindingDB Entry DOI: 10.7270/Q2S75H6Z
More data for this
Ligand-Target Pair
Glutamate receptor 2


(Homo sapiens (Human))
BDBM50373890
PNG
(CHEMBL429594)
Show SMILES N[C@@H](Cc1ns[nH]c1=O)C(O)=O |r|
Show InChI InChI=1S/C5H7N3O3S/c6-2(5(10)11)1-3-4(9)8-12-7-3/h2H,1,6H2,(H,8,9)(H,10,11)/t2-/m0/s1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
MMDB
PC cid
PC sid
UniChem

Similars

Article
PubMed
273n/an/an/an/an/an/an/an/a



University of Copenhagen

Curated by ChEMBL


Assay Description
Binding affinity at iGluR2o(R) receptor expressed in sf9 cells by radioligand binding assay


J Med Chem 51: 1459-63 (2008)


Article DOI: 10.1021/jm701126w
BindingDB Entry DOI: 10.7270/Q2S75H6Z
More data for this
Ligand-Target Pair
Glutamate receptor 2


(Homo sapiens (Human))
BDBM50373890
PNG
(CHEMBL429594)
Show SMILES N[C@@H](Cc1ns[nH]c1=O)C(O)=O |r|
Show InChI InChI=1S/C5H7N3O3S/c6-2(5(10)11)1-3-4(9)8-12-7-3/h2H,1,6H2,(H,8,9)(H,10,11)/t2-/m0/s1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
MMDB
PC cid
PC sid
UniChem

Similars

Article
PubMed
323n/an/an/an/an/an/an/an/a



University of Copenhagen

Curated by ChEMBL


Assay Description
Binding affinity at iGluR2 receptor S1S2J domain expressed in sf9 cells by radioligand binding assay


J Med Chem 51: 1459-63 (2008)


Article DOI: 10.1021/jm701126w
BindingDB Entry DOI: 10.7270/Q2S75H6Z
More data for this
Ligand-Target Pair
Glutamate receptor 2


(Homo sapiens (Human))
BDBM50373889
PNG
(CHEMBL402444)
Show SMILES N[C@H](Cc1ns[nH]c1=O)C(O)=O |r|
Show InChI InChI=1S/C5H7N3O3S/c6-2(5(10)11)1-3-4(9)8-12-7-3/h2H,1,6H2,(H,8,9)(H,10,11)/t2-/m1/s1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
MMDB
PC cid
PC sid
UniChem

Similars

Article
PubMed
531n/an/an/an/an/an/an/an/a



University of Copenhagen

Curated by ChEMBL


Assay Description
Binding affinity at iGluR2 receptor S1S2J domain expressed in sf9 cells by radioligand binding assay


J Med Chem 51: 1459-63 (2008)


Article DOI: 10.1021/jm701126w
BindingDB Entry DOI: 10.7270/Q2S75H6Z
More data for this
Ligand-Target Pair
Glutamate receptor 4


(Homo sapiens (Human))
BDBM50373889
PNG
(CHEMBL402444)
Show SMILES N[C@H](Cc1ns[nH]c1=O)C(O)=O |r|
Show InChI InChI=1S/C5H7N3O3S/c6-2(5(10)11)1-3-4(9)8-12-7-3/h2H,1,6H2,(H,8,9)(H,10,11)/t2-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
MMDB
PC cid
PC sid
UniChem

Similars

Article
PubMed
1.06E+3n/an/an/an/an/an/an/an/a



University of Copenhagen

Curated by ChEMBL


Assay Description
Binding affinity at iGluR4o receptor expressed in sf9 cells by radioligand binding assay


J Med Chem 51: 1459-63 (2008)


Article DOI: 10.1021/jm701126w
BindingDB Entry DOI: 10.7270/Q2S75H6Z
More data for this
Ligand-Target Pair
Glutamate receptor 3


(Homo sapiens (Human))
BDBM50373889
PNG
(CHEMBL402444)
Show SMILES N[C@H](Cc1ns[nH]c1=O)C(O)=O |r|
Show InChI InChI=1S/C5H7N3O3S/c6-2(5(10)11)1-3-4(9)8-12-7-3/h2H,1,6H2,(H,8,9)(H,10,11)/t2-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
MMDB
PC cid
PC sid
UniChem

Similars

MMDB
Article
PubMed
1.07E+3n/an/an/an/an/an/an/an/a



University of Copenhagen

Curated by ChEMBL


Assay Description
Binding affinity at iGluR3o receptor expressed in sf9 cells by radioligand binding assay


J Med Chem 51: 1459-63 (2008)


Article DOI: 10.1021/jm701126w
BindingDB Entry DOI: 10.7270/Q2S75H6Z
More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, kainate 1


(Homo sapiens (Human))
BDBM50373889
PNG
(CHEMBL402444)
Show SMILES N[C@H](Cc1ns[nH]c1=O)C(O)=O |r|
Show InChI InChI=1S/C5H7N3O3S/c6-2(5(10)11)1-3-4(9)8-12-7-3/h2H,1,6H2,(H,8,9)(H,10,11)/t2-/m1/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
MMDB
PC cid
PC sid
UniChem

Similars

Article
PubMed
>1.00E+4n/an/an/an/an/an/an/an/a



University of Copenhagen

Curated by ChEMBL


Assay Description
Binding affinity at iGluR5(Q) receptor expressed in sf9 cells by radioligand binding assay


J Med Chem 51: 1459-63 (2008)


Article DOI: 10.1021/jm701126w
BindingDB Entry DOI: 10.7270/Q2S75H6Z
More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, kainate 1


(Homo sapiens (Human))
BDBM50373890
PNG
(CHEMBL429594)
Show SMILES N[C@@H](Cc1ns[nH]c1=O)C(O)=O |r|
Show InChI InChI=1S/C5H7N3O3S/c6-2(5(10)11)1-3-4(9)8-12-7-3/h2H,1,6H2,(H,8,9)(H,10,11)/t2-/m0/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
MMDB
PC cid
PC sid
UniChem

Similars

Article
PubMed
1.85E+4n/an/an/an/an/an/an/an/a



University of Copenhagen

Curated by ChEMBL


Assay Description
Binding affinity at iGluR5(Q) receptor expressed in sf9 cells by radioligand binding assay


J Med Chem 51: 1459-63 (2008)


Article DOI: 10.1021/jm701126w
BindingDB Entry DOI: 10.7270/Q2S75H6Z
More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, kainate 2


(Homo sapiens (Human))
BDBM50373890
PNG
(CHEMBL429594)
Show SMILES N[C@@H](Cc1ns[nH]c1=O)C(O)=O |r|
Show InChI InChI=1S/C5H7N3O3S/c6-2(5(10)11)1-3-4(9)8-12-7-3/h2H,1,6H2,(H,8,9)(H,10,11)/t2-/m0/s1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
MMDB
PC cid
PC sid
UniChem

Similars

Article
PubMed
>1.00E+5n/an/an/an/an/an/an/an/a



University of Copenhagen

Curated by ChEMBL


Assay Description
Binding affinity at iGluR6(V,C,R) receptor expressed in sf9 cells by radioligand binding assay


J Med Chem 51: 1459-63 (2008)


Article DOI: 10.1021/jm701126w
BindingDB Entry DOI: 10.7270/Q2S75H6Z
More data for this
Ligand-Target Pair
Glutamate receptor ionotropic, kainate 2


(Homo sapiens (Human))
BDBM50373889
PNG
(CHEMBL402444)
Show SMILES N[C@H](Cc1ns[nH]c1=O)C(O)=O |r|
Show InChI InChI=1S/C5H7N3O3S/c6-2(5(10)11)1-3-4(9)8-12-7-3/h2H,1,6H2,(H,8,9)(H,10,11)/t2-/m1/s1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
MMDB
PC cid
PC sid
UniChem

Similars

Article
PubMed
>1.00E+6n/an/an/an/an/an/an/an/a



University of Copenhagen

Curated by ChEMBL


Assay Description
Binding affinity at iGluR6(V,C,R) receptor expressed in sf9 cells by radioligand binding assay


J Med Chem 51: 1459-63 (2008)


Article DOI: 10.1021/jm701126w
BindingDB Entry DOI: 10.7270/Q2S75H6Z
More data for this
Ligand-Target Pair
Cholecystokinin receptor type A


(Homo sapiens (Human))
BDBM50517344
PNG
(CHEMBL4526455)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(CS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)N(C)[C@H](CC(O)=O)C(=O)N(C)[C@@H](Cc1ccccc1)C(N)=O |r|
Show InChI InChI=1S/C91H137N13O27S/c1-6-7-32-68(89(121)104(5)75(55-83(114)115)90(122)103(4)74(84(92)116)52-62-29-23-22-24-30-62)100-87(119)72(53-65-56-95-67-33-28-27-31-66(65)67)98-78(107)57-96-85(117)70(50-61(2)3)101-86(118)71(51-63-36-38-64(39-37-63)60-132(125,126)127)102-88(120)73(54-82(112)113)99-80(109)59-131-49-47-129-45-43-94-79(108)58-130-48-46-128-44-42-93-76(105)41-40-69(91(123)124)97-77(106)34-25-20-18-16-14-12-10-8-9-11-13-15-17-19-21-26-35-81(110)111/h22-24,27-31,33,36-39,56,61,68-75,95H,6-21,25-26,32,34-35,40-55,57-60H2,1-5H3,(H2,92,116)(H,93,105)(H,94,108)(H,96,117)(H,97,106)(H,98,107)(H,99,109)(H,100,119)(H,101,118)(H,102,120)(H,110,111)(H,112,113)(H,114,115)(H,123,124)(H,125,126,127)/t68-,69-,70-,71-,72-,73-,74-,75+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.0407n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK1R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Cholecystokinin receptor type A


(Homo sapiens (Human))
BDBM50517358
PNG
(CHEMBL4585323)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)N(C)[C@H](CC(O)=O)C(=O)N(C)[C@@H](Cc1cccc2ccccc12)C(N)=O |r|
Show InChI InChI=1S/C92H133N13O28S/c1-6-7-32-69(90(122)105(5)76(55-84(115)116)91(123)104(4)75(85(93)117)53-63-29-26-28-62-27-22-23-30-66(62)63)101-88(120)73(52-64-56-96-68-33-25-24-31-67(64)68)99-79(108)57-97-86(118)71(50-60(2)3)102-87(119)72(51-61-36-38-65(39-37-61)133-134(126,127)128)103-89(121)74(54-83(113)114)100-81(110)59-132-49-47-130-45-43-95-80(109)58-131-48-46-129-44-42-94-77(106)41-40-70(92(124)125)98-78(107)34-20-18-16-14-12-10-8-9-11-13-15-17-19-21-35-82(111)112/h22-31,33,36-39,56,60,69-76,96H,6-21,32,34-35,40-55,57-59H2,1-5H3,(H2,93,117)(H,94,106)(H,95,109)(H,97,118)(H,98,107)(H,99,108)(H,100,110)(H,101,120)(H,102,119)(H,103,121)(H,111,112)(H,113,114)(H,115,116)(H,124,125)(H,126,127,128)/t69-,70-,71-,72-,73-,74-,75-,76+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.0427n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK1R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Cholecystokinin receptor type A


(Homo sapiens (Human))
BDBM50061829
PNG
((R)-N-((S)-1-Carbamoyl-2-phenyl-ethyl)-3-({(S)-2-[...)
Show SMILES CCCC[C@H](NC(=O)Cc1ccc(OS(O)(=O)=O)cc1)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCC)C(=O)N(C)[C@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
Show InChI InChI=1S/C47H60N8O13S/c1-4-6-16-35(51-40(56)24-30-19-21-32(22-20-30)68-69(65,66)67)44(61)50-28-41(57)52-38(25-31-27-49-34-18-12-11-15-33(31)34)45(62)53-36(17-7-5-2)47(64)55(3)39(26-42(58)59)46(63)54-37(43(48)60)23-29-13-9-8-10-14-29/h8-15,18-22,27,35-39,49H,4-7,16-17,23-26,28H2,1-3H3,(H2,48,60)(H,50,61)(H,51,56)(H,52,57)(H,53,62)(H,54,63)(H,58,59)(H,65,66,67)/t35-,36-,37-,38-,39+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
KEGG
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 0.0447n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK1R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Cholecystokinin receptor type A


(Homo sapiens (Human))
BDBM50517353
PNG
(CHEMBL4525615)
Show SMILES CSCC[C@H](NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)N(C)[C@H](CC(O)=O)C(=O)N(C)[C@@H](Cc1ccccc1)C(N)=O |r|
Show InChI InChI=1S/C86H127N13O28S3/c1-98(69(79(87)111)49-57-24-18-17-19-25-57)85(117)70(52-78(109)110)99(2)84(116)64(37-47-129-4)96-82(114)67(50-59-53-90-62-27-23-22-26-61(59)62)93-73(102)54-91-80(112)63(36-46-128-3)95-81(113)66(48-58-30-32-60(33-31-58)127-130(120,121)122)97-83(115)68(51-77(107)108)94-75(104)56-126-45-43-124-41-39-89-74(103)55-125-44-42-123-40-38-88-71(100)35-34-65(86(118)119)92-72(101)28-20-15-13-11-9-7-5-6-8-10-12-14-16-21-29-76(105)106/h17-19,22-27,30-33,53,63-70,90H,5-16,20-21,28-29,34-52,54-56H2,1-4H3,(H2,87,111)(H,88,100)(H,89,103)(H,91,112)(H,92,101)(H,93,102)(H,94,104)(H,95,113)(H,96,114)(H,97,115)(H,105,106)(H,107,108)(H,109,110)(H,118,119)(H,120,121,122)/t63-,64-,65-,66-,67-,68-,69-,70+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.0501n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK1R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Cholecystokinin receptor type A


(Homo sapiens (Human))
BDBM50517333
PNG
(CHEMBL4440419)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1ccc(CS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCC)C(=O)N(C)[C@H](CC(O)=O)C(=O)N(C)[C@@H](Cc1ccccc1)C(N)=O |r|
Show InChI InChI=1S/C89H133N13O27S/c1-5-7-31-66(83(115)94-56-76(105)96-70(52-63-55-93-65-33-27-26-30-64(63)65)85(117)99-67(32-8-6-2)87(119)102(4)73(54-81(112)113)88(120)101(3)72(82(90)114)51-60-28-22-21-23-29-60)98-84(116)69(50-61-36-38-62(39-37-61)59-130(123,124)125)100-86(118)71(53-80(110)111)97-78(107)58-129-49-47-127-45-43-92-77(106)57-128-48-46-126-44-42-91-74(103)41-40-68(89(121)122)95-75(104)34-24-19-17-15-13-11-9-10-12-14-16-18-20-25-35-79(108)109/h21-23,26-30,33,36-39,55,66-73,93H,5-20,24-25,31-32,34-35,40-54,56-59H2,1-4H3,(H2,90,114)(H,91,103)(H,92,106)(H,94,115)(H,95,104)(H,96,105)(H,97,107)(H,98,116)(H,99,117)(H,100,118)(H,108,109)(H,110,111)(H,112,113)(H,121,122)(H,123,124,125)/t66-,67-,68-,69-,70-,71-,72-,73+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.0525n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK1R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Cholecystokinin receptor type A


(Homo sapiens (Human))
BDBM50517373
PNG
(CHEMBL4514283)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCC)C(=O)N(C)[C@H](CC(O)=O)C(=O)N(C)[C@@H](Cc1ccccc1)C(N)=O |r|
Show InChI InChI=1S/C88H131N13O28S/c1-5-7-31-65(82(114)93-56-75(104)95-69(52-61-55-92-64-33-27-26-30-63(61)64)84(116)98-66(32-8-6-2)86(118)101(4)72(54-80(111)112)87(119)100(3)71(81(89)113)51-59-28-22-21-23-29-59)97-83(115)68(50-60-36-38-62(39-37-60)129-130(122,123)124)99-85(117)70(53-79(109)110)96-77(106)58-128-49-47-126-45-43-91-76(105)57-127-48-46-125-44-42-90-73(102)41-40-67(88(120)121)94-74(103)34-24-19-17-15-13-11-9-10-12-14-16-18-20-25-35-78(107)108/h21-23,26-30,33,36-39,55,65-72,92H,5-20,24-25,31-32,34-35,40-54,56-58H2,1-4H3,(H2,89,113)(H,90,102)(H,91,105)(H,93,114)(H,94,103)(H,95,104)(H,96,106)(H,97,115)(H,98,116)(H,99,117)(H,107,108)(H,109,110)(H,111,112)(H,120,121)(H,122,123,124)/t65-,66-,67-,68-,69-,70-,71-,72+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.0603n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK1R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Cholecystokinin receptor type A


(Homo sapiens (Human))
BDBM50517378
PNG
(CHEMBL4440303)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1ccc(CS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)COCCOCCNC(=O)[C@H](CCCCN)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCC)C(=O)N(C)[C@H](CC(O)=O)C(=O)N(C)[C@@H](Cc1ccccc1)C(N)=O |r|
Show InChI InChI=1S/C101H156N16O31S/c1-5-7-33-76(95(132)108-64-86(120)111-80(60-72-63-107-74-35-27-26-32-73(72)74)97(134)114-77(34-8-6-2)99(136)117(4)83(62-92(128)129)100(137)116(3)82(93(103)130)59-69-30-22-21-23-31-69)113-96(133)79(58-70-39-41-71(42-40-70)68-149(140,141)142)115-98(135)81(61-91(126)127)112-89(123)67-148-57-54-145-51-48-106-94(131)75(36-28-29-45-102)109-88(122)66-147-56-53-144-50-47-105-87(121)65-146-55-52-143-49-46-104-84(118)44-43-78(101(138)139)110-85(119)37-24-19-17-15-13-11-9-10-12-14-16-18-20-25-38-90(124)125/h21-23,26-27,30-32,35,39-42,63,75-83,107H,5-20,24-25,28-29,33-34,36-38,43-62,64-68,102H2,1-4H3,(H2,103,130)(H,104,118)(H,105,121)(H,106,131)(H,108,132)(H,109,122)(H,110,119)(H,111,120)(H,112,123)(H,113,133)(H,114,134)(H,115,135)(H,124,125)(H,126,127)(H,128,129)(H,138,139)(H,140,141,142)/t75-,76-,77-,78-,79-,80-,81-,82-,83+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.0631n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK1R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Cholecystokinin receptor type A


(Homo sapiens (Human))
BDBM50517375
PNG
(CHEMBL4483457)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1cc2ccccc2[nH]1)NC(=O)CNC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(C)=O)C(=O)N(C)[C@H](CC(O)=O)C(=O)N(C)[C@@H](Cc1ccccc1)C(N)=O |r|
Show InChI InChI=1S/C90H134N14O29S/c1-5-6-31-68(88(122)104(4)74(56-82(115)116)89(123)103(3)73(83(91)117)52-61-28-20-19-21-29-61)101-86(120)71(54-64-53-63-30-24-25-32-66(63)97-64)99-77(108)57-95-84(118)67(100-85(119)70(102-87(121)72(55-81(113)114)96-60(2)105)51-62-36-38-65(39-37-62)133-134(126,127)128)33-26-27-42-92-78(109)58-131-49-48-130-46-44-94-79(110)59-132-50-47-129-45-43-93-75(106)41-40-69(90(124)125)98-76(107)34-22-17-15-13-11-9-7-8-10-12-14-16-18-23-35-80(111)112/h19-21,24-25,28-30,32,36-39,53,67-74,97H,5-18,22-23,26-27,31,33-35,40-52,54-59H2,1-4H3,(H2,91,117)(H,92,109)(H,93,106)(H,94,110)(H,95,118)(H,96,105)(H,98,107)(H,99,108)(H,100,119)(H,101,120)(H,102,121)(H,111,112)(H,113,114)(H,115,116)(H,124,125)(H,126,127,128)/t67-,68-,69-,70-,71-,72-,73-,74+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.0646n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK1R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Cholecystokinin receptor type A


(Homo sapiens (Human))
BDBM50517368
PNG
(CHEMBL4441596)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCC)C(=O)N(C)[C@H](CC(O)=O)C(=O)N[C@@H](Cc1cccc2ccccc12)C(N)=O |r|
Show InChI InChI=1S/C91H131N13O28S/c1-4-6-32-68(85(117)96-57-78(107)98-73(53-63-56-95-67-34-25-24-31-66(63)67)87(119)101-69(33-7-5-2)90(122)104(3)75(55-83(114)115)89(121)102-71(84(92)116)52-62-29-26-28-61-27-22-23-30-65(61)62)100-86(118)72(51-60-37-39-64(40-38-60)132-133(125,126)127)103-88(120)74(54-82(112)113)99-80(109)59-131-50-48-129-46-44-94-79(108)58-130-49-47-128-45-43-93-76(105)42-41-70(91(123)124)97-77(106)35-20-18-16-14-12-10-8-9-11-13-15-17-19-21-36-81(110)111/h22-31,34,37-40,56,68-75,95H,4-21,32-33,35-36,41-55,57-59H2,1-3H3,(H2,92,116)(H,93,105)(H,94,108)(H,96,117)(H,97,106)(H,98,107)(H,99,109)(H,100,118)(H,101,119)(H,102,121)(H,103,120)(H,110,111)(H,112,113)(H,114,115)(H,123,124)(H,125,126,127)/t68-,69-,70-,71-,72-,73-,74-,75+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.0741n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK1R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Cholecystokinin receptor type A


(Homo sapiens (Human))
BDBM50517349
PNG
(CHEMBL4583158)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)N(C)[C@H](CC(O)=O)C(=O)N(C)[C@@H](Cc1ccccc1)C(N)=O |r|
Show InChI InChI=1S/C88H131N13O28S/c1-6-7-30-65(86(118)101(5)72(53-80(111)112)87(119)100(4)71(81(89)113)50-59-27-21-20-22-28-59)97-84(116)69(51-61-54-92-64-31-26-25-29-63(61)64)95-75(104)55-93-82(114)67(48-58(2)3)98-83(115)68(49-60-34-36-62(37-35-60)129-130(122,123)124)99-85(117)70(52-79(109)110)96-77(106)57-128-47-45-126-43-41-91-76(105)56-127-46-44-125-42-40-90-73(102)39-38-66(88(120)121)94-74(103)32-23-18-16-14-12-10-8-9-11-13-15-17-19-24-33-78(107)108/h20-22,25-29,31,34-37,54,58,65-72,92H,6-19,23-24,30,32-33,38-53,55-57H2,1-5H3,(H2,89,113)(H,90,102)(H,91,105)(H,93,114)(H,94,103)(H,95,104)(H,96,106)(H,97,116)(H,98,115)(H,99,117)(H,107,108)(H,109,110)(H,111,112)(H,120,121)(H,122,123,124)/t65-,66-,67-,68-,69-,70-,71-,72+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.0741n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK1R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Cholecystokinin receptor type A


(Homo sapiens (Human))
BDBM50517382
PNG
(CHEMBL4563364)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1cccc2ccccc12)C(N)=O |r|
Show InChI InChI=1S/C90H129N13O28S/c1-3-5-31-67(84(116)95-56-77(106)97-72(52-62-55-94-66-33-24-23-30-65(62)66)87(119)100-68(32-6-4-2)85(117)103-74(54-82(113)114)89(121)101-70(83(91)115)51-61-28-25-27-60-26-21-22-29-64(60)61)99-86(118)71(50-59-36-38-63(39-37-59)131-132(124,125)126)102-88(120)73(53-81(111)112)98-79(108)58-130-49-47-128-45-43-93-78(107)57-129-48-46-127-44-42-92-75(104)41-40-69(90(122)123)96-76(105)34-19-17-15-13-11-9-7-8-10-12-14-16-18-20-35-80(109)110/h21-30,33,36-39,55,67-74,94H,3-20,31-32,34-35,40-54,56-58H2,1-2H3,(H2,91,115)(H,92,104)(H,93,107)(H,95,116)(H,96,105)(H,97,106)(H,98,108)(H,99,118)(H,100,119)(H,101,121)(H,102,120)(H,103,117)(H,109,110)(H,111,112)(H,113,114)(H,122,123)(H,124,125,126)/t67-,68-,69-,70-,71-,72-,73-,74-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.0759n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK1R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Cholecystokinin receptor type A


(Homo sapiens (Human))
BDBM50517357
PNG
(CHEMBL4568746)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCC)C(=O)N(C)[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1cccc2ccccc12)C(N)=O |r|
Show InChI InChI=1S/C91H131N13O28S/c1-4-6-32-68(85(117)96-57-78(107)98-73(53-63-56-95-67-34-25-24-31-66(63)67)87(119)101-69(33-7-5-2)90(122)104(3)75(55-83(114)115)89(121)102-71(84(92)116)52-62-29-26-28-61-27-22-23-30-65(61)62)100-86(118)72(51-60-37-39-64(40-38-60)132-133(125,126)127)103-88(120)74(54-82(112)113)99-80(109)59-131-50-48-129-46-44-94-79(108)58-130-49-47-128-45-43-93-76(105)42-41-70(91(123)124)97-77(106)35-20-18-16-14-12-10-8-9-11-13-15-17-19-21-36-81(110)111/h22-31,34,37-40,56,68-75,95H,4-21,32-33,35-36,41-55,57-59H2,1-3H3,(H2,92,116)(H,93,105)(H,94,108)(H,96,117)(H,97,106)(H,98,107)(H,99,109)(H,100,118)(H,101,119)(H,102,121)(H,103,120)(H,110,111)(H,112,113)(H,114,115)(H,123,124)(H,125,126,127)/t68-,69-,70-,71-,72-,73-,74-,75-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.0794n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK1R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Cholecystokinin receptor type A


(Homo sapiens (Human))
BDBM50517361
PNG
(CHEMBL4534977)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1ccc(CS(O)(=O)=O)cc1)NC(=O)C[C@H](NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCC)C(=O)N(C)[C@H](CC(O)=O)C(=O)N(C)[C@@H](Cc1ccccc1)C(N)=O |r|
Show InChI InChI=1S/C89H133N13O27S/c1-5-7-31-66(83(114)94-56-77(106)97-70(52-63-55-93-65-33-27-26-30-64(63)65)85(116)100-67(32-8-6-2)86(117)102(4)73(54-81(111)112)87(118)101(3)72(82(90)113)51-60-28-22-21-23-29-60)99-84(115)69(50-61-36-38-62(39-37-61)59-130(123,124)125)96-76(105)53-71(89(121)122)98-79(108)58-129-49-47-127-45-43-92-78(107)57-128-48-46-126-44-42-91-74(103)41-40-68(88(119)120)95-75(104)34-24-19-17-15-13-11-9-10-12-14-16-18-20-25-35-80(109)110/h21-23,26-30,33,36-39,55,66-73,93H,5-20,24-25,31-32,34-35,40-54,56-59H2,1-4H3,(H2,90,113)(H,91,103)(H,92,107)(H,94,114)(H,95,104)(H,96,105)(H,97,106)(H,98,108)(H,99,115)(H,100,116)(H,109,110)(H,111,112)(H,119,120)(H,121,122)(H,123,124,125)/t66-,67-,68-,69-,70-,71-,72-,73+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.0794n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK1R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Cholecystokinin receptor type A


(Homo sapiens (Human))
BDBM50517376
PNG
(CHEMBL4473468)
Show SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N(C)[C@H](CC(O)=O)C(=O)N(C)[C@@H](Cc1ccccc1)C(N)=O |r|
Show InChI InChI=1S/C87H128N14O29S/c1-56(2)46-65(81(115)93-53-74(105)95-67(49-59-52-92-62-27-23-22-26-61(59)62)83(117)97-63(34-36-71(88)102)85(119)101(4)70(51-79(112)113)86(120)100(3)69(80(89)114)48-57-24-18-17-19-25-57)98-82(116)66(47-58-30-32-60(33-31-58)130-131(123,124)125)99-84(118)68(50-78(110)111)96-76(107)55-129-45-43-127-41-39-91-75(106)54-128-44-42-126-40-38-90-72(103)37-35-64(87(121)122)94-73(104)28-20-15-13-11-9-7-5-6-8-10-12-14-16-21-29-77(108)109/h17-19,22-27,30-33,52,56,63-70,92H,5-16,20-21,28-29,34-51,53-55H2,1-4H3,(H2,88,102)(H2,89,114)(H,90,103)(H,91,106)(H,93,115)(H,94,104)(H,95,105)(H,96,107)(H,97,117)(H,98,116)(H,99,118)(H,108,109)(H,110,111)(H,112,113)(H,121,122)(H,123,124,125)/t63-,64-,65-,66-,67-,68-,69-,70+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.0832n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK1R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Cholecystokinin receptor type A


(Homo sapiens (Human))
BDBM50517339
PNG
(CHEMBL4551834)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N(C)[C@@H](Cc1ccccc1)C(N)=O |r|
Show InChI InChI=1S/C87H129N13O28S/c1-5-6-29-64(82(114)99-70(52-79(110)111)86(118)100(4)71(80(88)112)49-58-26-20-19-21-27-58)96-84(116)68(50-60-53-91-63-30-25-24-28-62(60)63)94-74(103)54-92-81(113)66(47-57(2)3)97-83(115)67(48-59-33-35-61(36-34-59)128-129(121,122)123)98-85(117)69(51-78(108)109)95-76(105)56-127-46-44-125-42-40-90-75(104)55-126-45-43-124-41-39-89-72(101)38-37-65(87(119)120)93-73(102)31-22-17-15-13-11-9-7-8-10-12-14-16-18-23-32-77(106)107/h19-21,24-28,30,33-36,53,57,64-71,91H,5-18,22-23,29,31-32,37-52,54-56H2,1-4H3,(H2,88,112)(H,89,101)(H,90,104)(H,92,113)(H,93,102)(H,94,103)(H,95,105)(H,96,116)(H,97,115)(H,98,117)(H,99,114)(H,106,107)(H,108,109)(H,110,111)(H,119,120)(H,121,122,123)/t64-,65-,66-,67-,68-,69-,70-,71-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.0871n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK1R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Cholecystokinin receptor type A


(Homo sapiens (Human))
BDBM50517363
PNG
(CHEMBL4471871)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)N(C)[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r|
Show InChI InChI=1S/C87H129N13O28S/c1-5-6-29-64(86(118)100(4)71(52-79(110)111)85(117)97-66(80(88)112)48-58-26-20-19-21-27-58)96-83(115)69(50-60-53-91-63-30-25-24-28-62(60)63)94-74(103)54-92-81(113)67(47-57(2)3)98-82(114)68(49-59-33-35-61(36-34-59)128-129(121,122)123)99-84(116)70(51-78(108)109)95-76(105)56-127-46-44-125-42-40-90-75(104)55-126-45-43-124-41-39-89-72(101)38-37-65(87(119)120)93-73(102)31-22-17-15-13-11-9-7-8-10-12-14-16-18-23-32-77(106)107/h19-21,24-28,30,33-36,53,57,64-71,91H,5-18,22-23,29,31-32,37-52,54-56H2,1-4H3,(H2,88,112)(H,89,101)(H,90,104)(H,92,113)(H,93,102)(H,94,103)(H,95,105)(H,96,115)(H,97,117)(H,98,114)(H,99,116)(H,106,107)(H,108,109)(H,110,111)(H,119,120)(H,121,122,123)/t64-,65-,66-,67-,68-,69-,70-,71-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.0891n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK1R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Gastrin/cholecystokinin type B receptor


(Homo sapiens (Human))
BDBM50517382
PNG
(CHEMBL4563364)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1cccc2ccccc12)C(N)=O |r|
Show InChI InChI=1S/C90H129N13O28S/c1-3-5-31-67(84(116)95-56-77(106)97-72(52-62-55-94-66-33-24-23-30-65(62)66)87(119)100-68(32-6-4-2)85(117)103-74(54-82(113)114)89(121)101-70(83(91)115)51-61-28-25-27-60-26-21-22-29-64(60)61)99-86(118)71(50-59-36-38-63(39-37-59)131-132(124,125)126)102-88(120)73(53-81(111)112)98-79(108)58-130-49-47-128-45-43-93-78(107)57-129-48-46-127-44-42-92-75(104)41-40-69(90(122)123)96-76(105)34-19-17-15-13-11-9-7-8-10-12-14-16-18-20-35-80(109)110/h21-30,33,36-39,55,67-74,94H,3-20,31-32,34-35,40-54,56-58H2,1-2H3,(H2,91,115)(H,92,104)(H,93,107)(H,95,116)(H,96,105)(H,97,106)(H,98,108)(H,99,118)(H,100,119)(H,101,121)(H,102,120)(H,103,117)(H,109,110)(H,111,112)(H,113,114)(H,122,123)(H,124,125,126)/t67-,68-,69-,70-,71-,72-,73-,74-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.0933n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK2R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Cholecystokinin receptor type A


(Homo sapiens (Human))
BDBM50517340
PNG
(CHEMBL4550876)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)N(C)[C@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r|
Show InChI InChI=1S/C87H129N13O28S/c1-5-6-29-64(86(118)100(4)71(52-79(110)111)85(117)97-66(80(88)112)48-58-26-20-19-21-27-58)96-83(115)69(50-60-53-91-63-30-25-24-28-62(60)63)94-74(103)54-92-81(113)67(47-57(2)3)98-82(114)68(49-59-33-35-61(36-34-59)128-129(121,122)123)99-84(116)70(51-78(108)109)95-76(105)56-127-46-44-125-42-40-90-75(104)55-126-45-43-124-41-39-89-72(101)38-37-65(87(119)120)93-73(102)31-22-17-15-13-11-9-7-8-10-12-14-16-18-23-32-77(106)107/h19-21,24-28,30,33-36,53,57,64-71,91H,5-18,22-23,29,31-32,37-52,54-56H2,1-4H3,(H2,88,112)(H,89,101)(H,90,104)(H,92,113)(H,93,102)(H,94,103)(H,95,105)(H,96,115)(H,97,117)(H,98,114)(H,99,116)(H,106,107)(H,108,109)(H,110,111)(H,119,120)(H,121,122,123)/t64-,65-,66-,67-,68-,69-,70-,71+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.0977n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK1R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Cholecystokinin receptor type A


(Homo sapiens (Human))
BDBM50517346
PNG
(CHEMBL4467402)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(=O)N(C)[C@H](CC(O)=O)C(=O)N(C)[C@@H](Cc1ccccc1)C(N)=O |r|
Show InChI InChI=1S/C71H102N10O19S/c1-6-7-30-53(70(95)81(5)59(43-64(88)89)71(96)80(4)58(65(72)90)40-47-27-21-20-22-28-47)77-68(93)56(41-49-44-73-52-31-26-25-29-51(49)52)76-61(83)45-74-66(91)54(38-46(2)3)78-67(92)55(39-48-34-36-50(37-35-48)100-101(97,98)99)79-69(94)57(42-63(86)87)75-60(82)32-23-18-16-14-12-10-8-9-11-13-15-17-19-24-33-62(84)85/h20-22,25-29,31,34-37,44,46,53-59,73H,6-19,23-24,30,32-33,38-43,45H2,1-5H3,(H2,72,90)(H,74,91)(H,75,82)(H,76,83)(H,77,93)(H,78,92)(H,79,94)(H,84,85)(H,86,87)(H,88,89)(H,97,98,99)/t53-,54-,55-,56-,57-,58-,59+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.107n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK1R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Cholecystokinin receptor type A


(Homo sapiens (Human))
BDBM50517345
PNG
(CHEMBL4444353)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCNC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCC)C(=O)N(C)[C@H](CC(O)=O)C(=O)N(C)[C@@H](Cc1ccccc1)C(N)=O |r|
Show InChI InChI=1S/C122H199N13O44S/c1-5-7-31-99(116(148)127-92-111(140)130-103(88-95-91-126-98-33-27-26-30-97(95)98)118(150)132-100(32-8-6-2)120(152)135(4)106(90-114(145)146)121(153)134(3)105(115(123)147)87-93-28-22-21-23-29-93)131-117(149)102(86-94-36-38-96(39-37-94)179-180(156,157)158)133-119(151)104(89-113(143)144)129-110(139)43-47-160-51-55-164-59-63-168-67-71-172-75-79-176-83-85-178-81-77-174-73-69-170-65-61-166-57-53-162-49-45-125-108(137)42-46-159-50-54-163-58-62-167-66-70-171-74-78-175-82-84-177-80-76-173-72-68-169-64-60-165-56-52-161-48-44-124-107(136)41-40-101(122(154)155)128-109(138)34-24-19-17-15-13-11-9-10-12-14-16-18-20-25-35-112(141)142/h21-23,26-30,33,36-39,91,99-106,126H,5-20,24-25,31-32,34-35,40-90,92H2,1-4H3,(H2,123,147)(H,124,136)(H,125,137)(H,127,148)(H,128,138)(H,129,139)(H,130,140)(H,131,149)(H,132,150)(H,133,151)(H,141,142)(H,143,144)(H,145,146)(H,154,155)(H,156,157,158)/t99-,100-,101-,102-,103-,104-,105-,106+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.110n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK1R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Cholecystokinin receptor type A


(Homo sapiens (Human))
BDBM21147
PNG
((3S)-3-[(2S)-2-[(2S)-2-{2-[(2S)-2-[(2S)-2-[(3S)-3-...)
Show SMILES CSCC[C@H](NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@@H](N)CC(O)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
Show InChI InChI=1S/C49H62N10O16S3/c1-76-18-16-34(55-47(69)37(58-44(66)32(50)23-41(61)62)21-28-12-14-30(15-13-28)75-78(72,73)74)45(67)53-26-40(60)54-38(22-29-25-52-33-11-7-6-10-31(29)33)48(70)56-35(17-19-77-2)46(68)59-39(24-42(63)64)49(71)57-36(43(51)65)20-27-8-4-3-5-9-27/h3-15,25,32,34-39,52H,16-24,26,50H2,1-2H3,(H2,51,65)(H,53,67)(H,54,60)(H,55,69)(H,56,70)(H,57,71)(H,58,66)(H,59,68)(H,61,62)(H,63,64)(H,72,73,74)/t32-,34-,35-,36-,37-,38-,39-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
Purchase

CHEMBL
DrugBank
MCE
KEGG
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 0.112n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK1R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Cholecystokinin receptor type A


(Homo sapiens (Human))
BDBM50517377
PNG
(CHEMBL4445529)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)N(C)[C@@H](CC(O)=O)C(=O)N(C)[C@@H](Cc1cccc2ccccc12)C(N)=O |r|
Show InChI InChI=1S/C92H133N13O28S/c1-6-7-32-69(90(122)105(5)76(55-84(115)116)91(123)104(4)75(85(93)117)53-63-29-26-28-62-27-22-23-30-66(62)63)101-88(120)73(52-64-56-96-68-33-25-24-31-67(64)68)99-79(108)57-97-86(118)71(50-60(2)3)102-87(119)72(51-61-36-38-65(39-37-61)133-134(126,127)128)103-89(121)74(54-83(113)114)100-81(110)59-132-49-47-130-45-43-95-80(109)58-131-48-46-129-44-42-94-77(106)41-40-70(92(124)125)98-78(107)34-20-18-16-14-12-10-8-9-11-13-15-17-19-21-35-82(111)112/h22-31,33,36-39,56,60,69-76,96H,6-21,32,34-35,40-55,57-59H2,1-5H3,(H2,93,117)(H,94,106)(H,95,109)(H,97,118)(H,98,107)(H,99,108)(H,100,110)(H,101,120)(H,102,119)(H,103,121)(H,111,112)(H,113,114)(H,115,116)(H,124,125)(H,126,127,128)/t69-,70-,71-,72-,73-,74-,75-,76-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.115n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK1R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Gastrin/cholecystokinin type B receptor


(Homo sapiens (Human))
BDBM50517332
PNG
(CHEMBL4522865)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O |r|
Show InChI InChI=1S/C86H127N13O29S/c1-3-5-24-63(80(113)91-53-73(103)93-68(49-58-52-90-62-26-22-21-23-61(58)62)83(116)96-64(25-6-4-2)81(114)99-70(51-78(110)111)85(118)97-66(79(87)112)47-56-29-33-59(100)34-30-56)95-82(115)67(48-57-31-35-60(36-32-57)128-129(121,122)123)98-84(117)69(50-77(108)109)94-75(105)55-127-46-44-125-42-40-89-74(104)54-126-45-43-124-41-39-88-71(101)38-37-65(86(119)120)92-72(102)27-19-17-15-13-11-9-7-8-10-12-14-16-18-20-28-76(106)107/h21-23,26,29-36,52,63-70,90,100H,3-20,24-25,27-28,37-51,53-55H2,1-2H3,(H2,87,112)(H,88,101)(H,89,104)(H,91,113)(H,92,102)(H,93,103)(H,94,105)(H,95,115)(H,96,116)(H,97,118)(H,98,117)(H,99,114)(H,106,107)(H,108,109)(H,110,111)(H,119,120)(H,121,122,123)/t63-,64-,65-,66-,67-,68-,69-,70-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.132n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK2R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Gastrin/cholecystokinin type B receptor


(Homo sapiens (Human))
BDBM50517359
PNG
(CHEMBL4534236)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O |r|
Show InChI InChI=1S/C88H128N14O28S/c1-3-5-27-65(82(115)94-54-75(105)96-70(49-59-53-93-64-30-24-22-26-62(59)64)85(118)99-66(28-6-4-2)83(116)102-72(51-80(112)113)87(120)100-68(81(89)114)48-58-52-92-63-29-23-21-25-61(58)63)98-84(117)69(47-57-33-35-60(36-34-57)130-131(123,124)125)101-86(119)71(50-79(110)111)97-77(107)56-129-46-44-127-42-40-91-76(106)55-128-45-43-126-41-39-90-73(103)38-37-67(88(121)122)95-74(104)31-19-17-15-13-11-9-7-8-10-12-14-16-18-20-32-78(108)109/h21-26,29-30,33-36,52-53,65-72,92-93H,3-20,27-28,31-32,37-51,54-56H2,1-2H3,(H2,89,114)(H,90,103)(H,91,106)(H,94,115)(H,95,104)(H,96,105)(H,97,107)(H,98,117)(H,99,118)(H,100,120)(H,101,119)(H,102,116)(H,108,109)(H,110,111)(H,112,113)(H,121,122)(H,123,124,125)/t65-,66-,67-,68-,69-,70-,71-,72-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.132n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK2R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Gastrin/cholecystokinin type B receptor


(Homo sapiens (Human))
BDBM50517381
PNG
(CHEMBL4561184)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r|
Show InChI InChI=1S/C89H131N13O30S/c1-3-5-29-64(82(116)98-66(39-41-78(109)110)84(118)101-70(52-60-55-93-63-31-25-24-28-62(60)63)86(120)97-65(30-6-4-2)83(117)102-72(54-80(113)114)88(122)99-68(81(90)115)50-58-26-20-19-21-27-58)96-85(119)69(51-59-34-36-61(37-35-59)132-133(125,126)127)100-87(121)71(53-79(111)112)95-76(106)57-131-49-47-129-45-43-92-75(105)56-130-48-46-128-44-42-91-73(103)40-38-67(89(123)124)94-74(104)32-22-17-15-13-11-9-7-8-10-12-14-16-18-23-33-77(107)108/h19-21,24-28,31,34-37,55,64-72,93H,3-18,22-23,29-30,32-33,38-54,56-57H2,1-2H3,(H2,90,115)(H,91,103)(H,92,105)(H,94,104)(H,95,106)(H,96,119)(H,97,120)(H,98,116)(H,99,122)(H,100,121)(H,101,118)(H,102,117)(H,107,108)(H,109,110)(H,111,112)(H,113,114)(H,123,124)(H,125,126,127)/t64-,65-,66-,67-,68-,69-,70-,71-,72-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.151n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK2R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Cholecystokinin receptor type A


(Homo sapiens (Human))
BDBM50517365
PNG
(CHEMBL4544208)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(CS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)N(C)[C@H](CC(O)=O)C(=O)N(C)[C@@H](Cc1ccccc1)C(N)=O |r|
Show InChI InChI=1S/C85H125N13O27S/c1-6-7-26-62(83(115)98(5)69(49-77(108)109)84(116)97(4)68(78(86)110)46-56-23-17-16-18-24-56)94-81(113)66(47-59-50-89-61-27-22-21-25-60(59)61)92-72(101)51-90-79(111)64(44-55(2)3)95-80(112)65(45-57-30-32-58(33-31-57)54-126(119,120)121)96-82(114)67(48-76(106)107)93-74(103)53-125-43-41-123-39-37-88-73(102)52-124-42-40-122-38-36-87-70(99)35-34-63(85(117)118)91-71(100)28-19-14-12-10-8-9-11-13-15-20-29-75(104)105/h16-18,21-25,27,30-33,50,55,62-69,89H,6-15,19-20,26,28-29,34-49,51-54H2,1-5H3,(H2,86,110)(H,87,99)(H,88,102)(H,90,111)(H,91,100)(H,92,101)(H,93,103)(H,94,113)(H,95,112)(H,96,114)(H,104,105)(H,106,107)(H,108,109)(H,117,118)(H,119,120,121)/t62-,63-,64-,65-,66-,67-,68-,69+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.155n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK1R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Gastrin/cholecystokinin type B receptor


(Homo sapiens (Human))
BDBM50517367
PNG
(CHEMBL4468861)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r|
Show InChI InChI=1S/C85H123N13O30S/c1-2-3-26-61(80(114)98-68(50-77(110)111)84(118)96-64(78(86)112)46-55-23-17-16-18-24-55)94-82(116)66(48-57-51-89-60-27-22-21-25-59(57)60)92-71(101)52-90-79(113)62(35-37-75(106)107)95-81(115)65(47-56-30-32-58(33-31-56)128-129(121,122)123)97-83(117)67(49-76(108)109)93-73(103)54-127-45-43-125-41-39-88-72(102)53-126-44-42-124-40-38-87-69(99)36-34-63(85(119)120)91-70(100)28-19-14-12-10-8-6-4-5-7-9-11-13-15-20-29-74(104)105/h16-18,21-25,27,30-33,51,61-68,89H,2-15,19-20,26,28-29,34-50,52-54H2,1H3,(H2,86,112)(H,87,99)(H,88,102)(H,90,113)(H,91,100)(H,92,101)(H,93,103)(H,94,116)(H,95,115)(H,96,118)(H,97,117)(H,98,114)(H,104,105)(H,106,107)(H,108,109)(H,110,111)(H,119,120)(H,121,122,123)/t61-,62-,63-,64-,65-,66-,67-,68-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.158n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK2R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Gastrin/cholecystokinin type B receptor


(Homo sapiens (Human))
BDBM50517362
PNG
(CHEMBL4565336)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r|
Show InChI InChI=1S/C86H127N13O28S/c1-4-5-28-63(81(113)99-70(51-78(109)110)85(117)96-65(79(87)111)47-57-25-19-18-20-26-57)95-83(115)68(49-59-52-90-62-29-24-23-27-61(59)62)93-73(102)53-91-80(112)66(46-56(2)3)97-82(114)67(48-58-32-34-60(35-33-58)127-128(120,121)122)98-84(116)69(50-77(107)108)94-75(104)55-126-45-43-124-41-39-89-74(103)54-125-44-42-123-40-38-88-71(100)37-36-64(86(118)119)92-72(101)30-21-16-14-12-10-8-6-7-9-11-13-15-17-22-31-76(105)106/h18-20,23-27,29,32-35,52,56,63-70,90H,4-17,21-22,28,30-31,36-51,53-55H2,1-3H3,(H2,87,111)(H,88,100)(H,89,103)(H,91,112)(H,92,101)(H,93,102)(H,94,104)(H,95,115)(H,96,117)(H,97,114)(H,98,116)(H,99,113)(H,105,106)(H,107,108)(H,109,110)(H,118,119)(H,120,121,122)/t63-,64-,65-,66-,67-,68-,69-,70-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.166n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK2R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Cholecystokinin receptor type A


(Homo sapiens (Human))
BDBM50517343
PNG
(CHEMBL4520976)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(CS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)N(C)[C@H](CC(O)=O)C(=O)N(C)[C@@H](Cc1ccccc1)C(N)=O |r|
Show InChI InChI=1S/C87H129N13O27S/c1-6-7-28-64(85(117)100(5)71(51-79(110)111)86(118)99(4)70(80(88)112)48-58-25-19-18-20-26-58)96-83(115)68(49-61-52-91-63-29-24-23-27-62(61)63)94-74(103)53-92-81(113)66(46-57(2)3)97-82(114)67(47-59-32-34-60(35-33-59)56-128(121,122)123)98-84(116)69(50-78(108)109)95-76(105)55-127-45-43-125-41-39-90-75(104)54-126-44-42-124-40-38-89-72(101)37-36-65(87(119)120)93-73(102)30-21-16-14-12-10-8-9-11-13-15-17-22-31-77(106)107/h18-20,23-27,29,32-35,52,57,64-71,91H,6-17,21-22,28,30-31,36-51,53-56H2,1-5H3,(H2,88,112)(H,89,101)(H,90,104)(H,92,113)(H,93,102)(H,94,103)(H,95,105)(H,96,115)(H,97,114)(H,98,116)(H,106,107)(H,108,109)(H,110,111)(H,119,120)(H,121,122,123)/t64-,65-,66-,67-,68-,69-,70-,71+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.200n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK1R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Gastrin/cholecystokinin type B receptor


(Homo sapiens (Human))
BDBM50517384
PNG
(CHEMBL4443415)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r|
Show InChI InChI=1S/C86H127N13O28S/c1-3-5-29-63(80(112)91-54-73(102)93-68(50-59-53-90-62-31-25-24-28-61(59)62)83(115)96-64(30-6-4-2)81(113)99-70(52-78(109)110)85(117)97-66(79(87)111)48-57-26-20-19-21-27-57)95-82(114)67(49-58-34-36-60(37-35-58)127-128(120,121)122)98-84(116)69(51-77(107)108)94-75(104)56-126-47-45-124-43-41-89-74(103)55-125-46-44-123-42-40-88-71(100)39-38-65(86(118)119)92-72(101)32-22-17-15-13-11-9-7-8-10-12-14-16-18-23-33-76(105)106/h19-21,24-28,31,34-37,53,63-70,90H,3-18,22-23,29-30,32-33,38-52,54-56H2,1-2H3,(H2,87,111)(H,88,100)(H,89,103)(H,91,112)(H,92,101)(H,93,102)(H,94,104)(H,95,114)(H,96,115)(H,97,117)(H,98,116)(H,99,113)(H,105,106)(H,107,108)(H,109,110)(H,118,119)(H,120,121,122)/t63-,64-,65-,66-,67-,68-,69-,70-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.209n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK2R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Cholecystokinin receptor type A


(Homo sapiens (Human))
BDBM50517379
PNG
(CHEMBL4453982)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(CS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r|
Show InChI InChI=1S/C87H129N13O27S/c1-4-5-28-64(82(114)100-71(51-79(110)111)86(118)97-66(80(88)112)47-58-25-19-18-20-26-58)96-84(116)69(49-61-52-91-63-29-24-23-27-62(61)63)94-74(103)53-92-81(113)67(46-57(2)3)98-83(115)68(48-59-32-34-60(35-33-59)56-128(121,122)123)99-85(117)70(50-78(108)109)95-76(105)55-127-45-43-125-41-39-90-75(104)54-126-44-42-124-40-38-89-72(101)37-36-65(87(119)120)93-73(102)30-21-16-14-12-10-8-6-7-9-11-13-15-17-22-31-77(106)107/h18-20,23-27,29,32-35,52,57,64-71,91H,4-17,21-22,28,30-31,36-51,53-56H2,1-3H3,(H2,88,112)(H,89,101)(H,90,104)(H,92,113)(H,93,102)(H,94,103)(H,95,105)(H,96,116)(H,97,118)(H,98,115)(H,99,117)(H,100,114)(H,106,107)(H,108,109)(H,110,111)(H,119,120)(H,121,122,123)/t64-,65-,66-,67-,68-,69-,70-,71-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.245n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK1R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Cholecystokinin receptor type A


(Homo sapiens (Human))
BDBM50517384
PNG
(CHEMBL4443415)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r|
Show InChI InChI=1S/C86H127N13O28S/c1-3-5-29-63(80(112)91-54-73(102)93-68(50-59-53-90-62-31-25-24-28-61(59)62)83(115)96-64(30-6-4-2)81(113)99-70(52-78(109)110)85(117)97-66(79(87)111)48-57-26-20-19-21-27-57)95-82(114)67(49-58-34-36-60(37-35-58)127-128(120,121)122)98-84(116)69(51-77(107)108)94-75(104)56-126-47-45-124-43-41-89-74(103)55-125-46-44-123-42-40-88-71(100)39-38-65(86(118)119)92-72(101)32-22-17-15-13-11-9-7-8-10-12-14-16-18-23-33-76(105)106/h19-21,24-28,31,34-37,53,63-70,90H,3-18,22-23,29-30,32-33,38-52,54-56H2,1-2H3,(H2,87,111)(H,88,100)(H,89,103)(H,91,112)(H,92,101)(H,93,102)(H,94,104)(H,95,114)(H,96,115)(H,97,117)(H,98,116)(H,99,113)(H,105,106)(H,107,108)(H,109,110)(H,118,119)(H,120,121,122)/t63-,64-,65-,66-,67-,68-,69-,70-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.245n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK1R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Cholecystokinin receptor type A


(Homo sapiens (Human))
BDBM50517342
PNG
(CHEMBL4591101)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCC)C(=O)N[C@H](CC(O)=O)C(=O)N(C)[C@@H](Cc1ccccc1)C(N)=O |r|
Show InChI InChI=1S/C87H129N13O28S/c1-4-6-30-64(81(113)92-55-74(103)94-68(51-60-54-91-63-32-26-25-29-62(60)63)84(116)97-65(31-7-5-2)82(114)99-70(53-79(110)111)86(118)100(3)71(80(88)112)50-58-27-21-20-22-28-58)96-83(115)67(49-59-35-37-61(38-36-59)128-129(121,122)123)98-85(117)69(52-78(108)109)95-76(105)57-127-48-46-125-44-42-90-75(104)56-126-47-45-124-43-41-89-72(101)40-39-66(87(119)120)93-73(102)33-23-18-16-14-12-10-8-9-11-13-15-17-19-24-34-77(106)107/h20-22,25-29,32,35-38,54,64-71,91H,4-19,23-24,30-31,33-34,39-53,55-57H2,1-3H3,(H2,88,112)(H,89,101)(H,90,104)(H,92,113)(H,93,102)(H,94,103)(H,95,105)(H,96,115)(H,97,116)(H,98,117)(H,99,114)(H,106,107)(H,108,109)(H,110,111)(H,119,120)(H,121,122,123)/t64-,65-,66-,67-,68-,69-,70+,71-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.263n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK1R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Cholecystokinin receptor type A


(Homo sapiens (Human))
BDBM50517362
PNG
(CHEMBL4565336)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r|
Show InChI InChI=1S/C86H127N13O28S/c1-4-5-28-63(81(113)99-70(51-78(109)110)85(117)96-65(79(87)111)47-57-25-19-18-20-26-57)95-83(115)68(49-59-52-90-62-29-24-23-27-61(59)62)93-73(102)53-91-80(112)66(46-56(2)3)97-82(114)67(48-58-32-34-60(35-33-58)127-128(120,121)122)98-84(116)69(50-77(107)108)94-75(104)55-126-45-43-124-41-39-89-74(103)54-125-44-42-123-40-38-88-71(100)37-36-64(86(118)119)92-72(101)30-21-16-14-12-10-8-6-7-9-11-13-15-17-22-31-76(105)106/h18-20,23-27,29,32-35,52,56,63-70,90H,4-17,21-22,28,30-31,36-51,53-55H2,1-3H3,(H2,87,111)(H,88,100)(H,89,103)(H,91,112)(H,92,101)(H,93,102)(H,94,104)(H,95,115)(H,96,117)(H,97,114)(H,98,116)(H,99,113)(H,105,106)(H,107,108)(H,109,110)(H,118,119)(H,120,121,122)/t63-,64-,65-,66-,67-,68-,69-,70-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.275n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK1R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Gastrin/cholecystokinin type B receptor


(Homo sapiens (Human))
BDBM50517339
PNG
(CHEMBL4551834)
Show SMILES CCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N(C)[C@@H](Cc1ccccc1)C(N)=O |r|
Show InChI InChI=1S/C87H129N13O28S/c1-5-6-29-64(82(114)99-70(52-79(110)111)86(118)100(4)71(80(88)112)49-58-26-20-19-21-27-58)96-84(116)68(50-60-53-91-63-30-25-24-28-62(60)63)94-74(103)54-92-81(113)66(47-57(2)3)97-83(115)67(48-59-33-35-61(36-34-59)128-129(121,122)123)98-85(117)69(51-78(108)109)95-76(105)56-127-46-44-125-42-40-90-75(104)55-126-45-43-124-41-39-89-72(101)38-37-65(87(119)120)93-73(102)31-22-17-15-13-11-9-7-8-10-12-14-16-18-23-32-77(106)107/h19-21,24-28,30,33-36,53,57,64-71,91H,5-18,22-23,29,31-32,37-52,54-56H2,1-4H3,(H2,88,112)(H,89,101)(H,90,104)(H,92,113)(H,93,102)(H,94,103)(H,95,105)(H,96,116)(H,97,115)(H,98,117)(H,99,114)(H,106,107)(H,108,109)(H,110,111)(H,119,120)(H,121,122,123)/t64-,65-,66-,67-,68-,69-,70-,71-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
KEGG
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.288n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK2R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Gastrin/cholecystokinin type B receptor


(Homo sapiens (Human))
BDBM21147
PNG
((3S)-3-[(2S)-2-[(2S)-2-{2-[(2S)-2-[(2S)-2-[(3S)-3-...)
Show SMILES CSCC[C@H](NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@@H](N)CC(O)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
Show InChI InChI=1S/C49H62N10O16S3/c1-76-18-16-34(55-47(69)37(58-44(66)32(50)23-41(61)62)21-28-12-14-30(15-13-28)75-78(72,73)74)45(67)53-26-40(60)54-38(22-29-25-52-33-11-7-6-10-31(29)33)48(70)56-35(17-19-77-2)46(68)59-39(24-42(63)64)49(71)57-36(43(51)65)20-27-8-4-3-5-9-27/h3-15,25,32,34-39,52H,16-24,26,50H2,1-2H3,(H2,51,65)(H,53,67)(H,54,60)(H,55,69)(H,56,70)(H,57,71)(H,58,66)(H,59,68)(H,61,62)(H,63,64)(H,72,73,74)/t32-,34-,35-,36-,37-,38-,39-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
Purchase

CHEMBL
DrugBank
MCE
KEGG
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 0.288n/an/an/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Displacement of [125I]-CCK-8 from human CCK2R expressed in human 1321N1 cell membranes after 2 hrs by SPA assay


J Med Chem 62: 1407-1419 (2019)


Article DOI: 10.1021/acs.jmedchem.8b01558
BindingDB Entry DOI: 10.7270/Q2K64NF5
More data for this
Ligand-Target Pair
Displayed 1 to 50 (of 238 total )  |  Next  |  Last  >>
Jump to: